Scholar Rock Holding Corp

By person

31 insiders · 188 transactions

141×

David Hallal holds 141 times base salary in stock. $90.09M of shares against $637.50K in salary for 2025.

Salary from the company's own proxy. The shares are what David Hallal last reported holding, valued at $54.96, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Invus Public Equities, L.P.

10% owner

$17.55M (7)

$82.41M (7)

−$64.86M

9,250,005

7.60%

$508.42M

+5.7%

Myles Edward H

COO & CFO

—

$16.81M (19) scheduled

−$16.81M

111,345

0.0914%

$6.12M

−70.1%

Samsara BioCapital GP, LLC entity

10% owner

$15.00M (1)

—

+$15.00M

6,788,609

5.57%

$373.13M

+47.6%

Qatanani Mo

CHIEF SCIENTIFIC OFFICER

—

$13.37M (24) scheduled

−$13.37M

98,445

0.0808%

$5.41M

−0.5%

Nashat Amir

Director

$7.87M (4)

—

+$7.87M

38,639

0.0317%

$2.12M

—

Artal International S.C.A.

10% owner

$6.30M (1)

—

+$6.30M

2,396,040

1.97%

$131.70M

—

Marantz Jing L.

CHIEF MEDICAL OFFICER

—

$4.06M (12) scheduled

−$4.06M

126,012

0.1035%

$6.93M

—

Hallal David

Chief Executive Officer

—

$3.97M (2)

−$3.97M

1,639,034

1.35%

$90.09M

+460.2%

Carven Gregory John

Chief Scientific Officer

—

$3.27M (8) scheduled

−$3.27M

128,208

0.1053%

$7.05M

+134.8%

FLIER JEFFREY S.

Director

—

$2.21M (13) scheduled

−$2.21M

27,856

0.0229%

$1.53M

−36.4%

Polaris Venture Management Co. VI, L.L.C. entity

10% owner

$2.00M (2)

—

+$2.00M

156,395

0.1284%

$8.60M

—

Backstrom Jay T.

CHIEF EXECUTIVE OFFICER

—

$1.85M (3)

−$1.85M

425,561

0.3494%

$23.39M

—

Ho Junlin

GENERAL COUNSEL

—

$1.82M (8)

−$1.82M

241,545

0.1983%

$13.28M

+525.2%

Vaishnaw Akshay

President of R&D

—

$1.68M (4)

−$1.68M

630,542

0.5177%

$34.66M

+6,569%

Parlavecchio Caryn

CHRO

—

$1.63M (11)

−$1.63M

169,087

0.1388%

$9.29M

+281.7%

Sacco Tracey

Chief Commercial Officer

—

$1.32M (7) scheduled

−$1.32M

71,750

0.0589%

$3.94M

—

Sinha Vikas

Chief Financial Officer

—

$1.23M (2)

−$1.23M

619,856

0.5090%

$34.07M

—

Woods Keith

Chief Operating Officer

—

$1.22M (2)

−$1.22M

620,055

0.5091%

$34.08M

—

SPRINGER TIMOTHY A

10% owner

$999.99K (1)

—

+$999.99K

2,376,567

1.95%

$130.63M

+64.5%

Gilman Michael

Director

—

$870.19K (10) scheduled

−$870.19K

59,511

0.0489%

$3.27M

+35.4%

AKKARAJU SRINIVAS

Director

$34.99M (10)

$34.39M (3) scheduled

+$603.31K

6,395,585

5.25%

$351.53M

+70.2%

Peng Katie

Director

—

$502.00K (10) scheduled

−$502.00K

34,301

0.0282%

$1.89M

—

Moore Erin

Interim PFO and PAO

—

$449.24K (1) scheduled

−$449.24K

82,609

0.0678%

$4.54M

0.0%

Burow Kristina

Director

—

$324.57K (4) scheduled

−$324.57K

2,460,368

2.02%

$135.23M

—

Reed Joshua

Director

—

$324.53K (4) scheduled

−$324.53K

19,518

0.0160%

$1.07M

—

Brudnick Richard

Director

—

$180.53K (2) scheduled

−$180.53K

21,896

0.0180%

$1.20M

—

Invus Global Management, LLC entity

10% owner

—

10,825,013

8.89%

$594.99M

+17.0%

ARCH Venture Fund VIII, L.P. entity

10% owner

—

2,637,617

2.17%

$144.97M

—

Mahanthappa Nagesh K.

Interim CEO and President

—

480,491

0.3945%

$26.41M

+26.3%

CHYUNG YUNG H.

Chief Medical Officer

—

258,496

0.2123%

$14.21M

+25.1%

Kingsley Stuart A

President and CEO

—

42,000

0.0345%

$2.31M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Qatanani Mo

14 Jan 2026

CHIEF SCIENTIFIC OFFICER

Sold after exercise

13,112

$45.20

$592.61K

Qatanani Mo

4 Dec 2025

CHIEF SCIENTIFIC OFFICER

Sold after exercise

136,462

$45.21

$6.17M

FLIER JEFFREY S.

23 Jun 2025

Director

Sold after exercise indirect

11,136

$33.21

$369.82K

FLIER JEFFREY S.

23 Jun 2025

Director

Sold after exercise

2,766

$32.74

$90.55K

FLIER JEFFREY S.

23 Jun 2025

Director

Sold after exercise

17,550

$32.16

$564.36K

Sacco Tracey

25 Apr 2025

Chief Commercial Officer

Sold after exercise

$33.49

$2.81K

Sacco Tracey

25 Apr 2025

Chief Commercial Officer

Sold after exercise

4,916

$32.81

$161.32K

Moore Erin

24 Mar 2025

Interim PFO and PAO

Sold after exercise

13,564

$33.12

$449.24K

Sacco Tracey

24 Mar 2025

Chief Commercial Officer

Sold after exercise

5,000

$32.89

$164.46K

Sacco Tracey

24 Mar 2025

Chief Commercial Officer

Sold after exercise

1,500

$33.70

$50.56K

Myles Edward H

10 Mar 2025

COO & CFO

Sold after exercise

29,395

$34.87

$1.03M

Myles Edward H

10 Mar 2025

COO & CFO

Sold after exercise

112,897

$35.82

$4.04M

Qatanani Mo

19 Feb 2025

CHIEF SCIENTIFIC OFFICER

Sold after exercise

20,202

$37.74

$762.50K

Qatanani Mo

19 Feb 2025

CHIEF SCIENTIFIC OFFICER

Sold after exercise

8,341

$37.56

$313.29K

Qatanani Mo

19 Feb 2025

CHIEF SCIENTIFIC OFFICER

Sold after exercise

39,967

$37.20

$1.49M

Marantz Jing L.

25 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

200

$40.72

$8.14K

Marantz Jing L.

25 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

3,075

$39.93

$122.78K

Marantz Jing L.

25 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

2,100

$39.25

$82.43K

Marantz Jing L.

25 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

1,000

$38.04

$38.04K

Marantz Jing L.

22 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

2,145

$30.01

$64.37K

Marantz Jing L.

11 Nov 2024

CHIEF MEDICAL OFFICER

Sold after exercise

2,105

$30.00

$63.16K

Myles Edward H

8 Oct 2024

COO & CFO

Sold after exercise

37,187

$34.90

$1.30M

Marantz Jing L.

7 Oct 2024

CHIEF MEDICAL OFFICER

Sold after exercise

39,375

$30.06

$1.18M

Marantz Jing L.

7 Oct 2024

CHIEF MEDICAL OFFICER

Sold after exercise

2,552

$26.22

$66.92K

Marantz Jing L.

7 Oct 2024

CHIEF MEDICAL OFFICER

Sold after exercise

67,448

$25.59

$1.73M

Sacco Tracey

7 Oct 2024

CHIEF COMMERCIAL OFFICER

Sold after exercise

1,964

$26.23

$51.52K

Sacco Tracey

7 Oct 2024

CHIEF COMMERCIAL OFFICER

Sold after exercise

28,036

$25.58

$717.16K

Myles Edward H

7 Oct 2024

COO & CFO

Sold after exercise

31,250

$29.05

$907.81K

Myles Edward H

7 Oct 2024

COO & CFO

Sold after exercise

25,812

$27.27

$703.89K

Myles Edward H

7 Oct 2024

COO & CFO

Sold after exercise

37,206

$26.83

$998.24K

Myles Edward H

7 Oct 2024

COO & CFO

Sold after exercise

111,972

$25.61

$2.87M

Myles Edward H

29 Dec 2023

COO & CFO

Sold after exercise

300

$19.51

$5.85K

Myles Edward H

29 Dec 2023

COO & CFO

Sold after exercise

12,159

$18.82

$228.78K

Qatanani Mo

14 Dec 2023

SVP AND HEAD OF RESEARCH

Sold after exercise

24,662

$18.18

$448.44K

Myles Edward H

7 Dec 2023

COO & CFO

Sold after exercise

24,914

$17.53

$436.82K

Myles Edward H

15 Nov 2021

Chief Financial Officer

Sold after exercise

4,879

$35.05

$171.01K

Myles Edward H

12 Nov 2021

Chief Financial Officer

Sold after exercise

49,848

$35.12

$1.75M

Myles Edward H

11 Nov 2021

Chief Financial Officer

Sold after exercise

23,574

$35.20

$829.86K

Carven Gregory John

27 Jan 2021

Head of Research

Sold after exercise

1,561

$57.79

$90.21K

Carven Gregory John

27 Jan 2021

Head of Research

Sold after exercise

12,139

$56.72

$688.51K

Carven Gregory John

27 Jan 2021

Head of Research

Sold after exercise

5,400

$55.87

$301.68K

Carven Gregory John

26 Jan 2021

Head of Research

Sold after exercise

1,064

$61.52

$65.45K

Carven Gregory John

26 Jan 2021

Head of Research

Sold after exercise

8,417

$60.65

$510.49K

Carven Gregory John

26 Jan 2021

Head of Research

Sold after exercise

9,249

$59.69

$552.10K

Carven Gregory John

26 Jan 2021

Head of Research

Sold after exercise

13,368

$58.79

$785.97K

Carven Gregory John

26 Jan 2021

Head of Research

Sold after exercise

4,676

$57.91

$270.81K

Gilman Michael

26 Jan 2021

Director

Sold after exercise

1,518

$59.90

$90.93K

Gilman Michael

26 Jan 2021

Director

Sold after exercise

1,500

$59.02

$88.53K

Gilman Michael

26 Jan 2021

Director

Sold after exercise

483

$57.99

$28.01K

Show all 188 transactions →

Scholar Rock Holding Corp

By person

Individual transactions

What was left out